Sonia Portillo, Author at Onco'Zine

1282 POSTS 0 COMMENTS

Sonia Portillo is an associate editor of ADC Review | Journal of Antibody-Drug Conjugates, an online, peer reviewed publication dedicated to following the developments of ADCs and other targeted therapies and a contributing editor to Onco'Zine. Portillo studies cancer treatment from a pharmacological perspective, specifically in the area of precision and personalized medicine.

Study Reveals Higher Risks of HPV-Related Cancers in HIV-Infected Hispanic Adults

Sonia Portillo - October 24, 2018

Executives from American Express and J.P. Morgan Join St. Baldrick’s Foundation...

Sonia Portillo - October 24, 2018

Phase Ib/II Data of Durvalumab Plus Danvatirsen Shows Promise in Head...

Sonia Portillo - October 22, 2018

Nivolumab + Low-dose Ipilimumab may be First Line Treatment in Some...

Sonia Portillo - October 22, 2018

Novartis Plans to Acquire Endocyte to Expand Expertise in Radiopharmaceuticals

Sonia Portillo - October 21, 2018

Dana-Farber to Investigate New Therapy for Brain Cancer

Sonia Portillo - October 21, 2018

Study of AXL Inhibitor DS-1205 in EGFR-Mutated Metastatic Non-Small Cell Lung...

Sonia Portillo - October 19, 2018

Featured image: Encouraging mother with breast cancer. 2018-2020 Fotolia/Adobe. used with permission.

Novel Statistical Method Estimates Time to Metastasis of Breast Cancer

Sonia Portillo - October 19, 2018

NanoValent Receives NIH SBIR Funding for Antibody-conjugated Nanoparticle Technology

Sonia Portillo - October 1, 2018

Study Confirms CT Screening for Nodule Volume Management Reduces Lung Cancer...

Sonia Portillo - September 26, 2018

12 3...129 Page 1 of 129

LATEST NEWS

October Breast Cancer Awareness Month: Emphasizing Equity in Access to Early Detection

Danielle Garcia - September 20, 2023

Breaking Barriers to Access: Empowering Vulnerable Populations with Cell and Gene Therapy

Jennifer Klarer - September 18, 2023

Understanding the True Impact of Microbiota on Cancer Development and Treatment

Peter Hofland - September 18, 2023

Language Barriers and the Impact on Cancer Care

Peter Hofland - September 16, 2023

Long-term Outcomes of Radiation Techniques for the Treatment of Locally Advanced NSCLC

Peter Hofland - September 12, 2023

Press Releases | Cancer

Addressing PCOS Hirsutism Effectively: Dr. Davin Lim Backs Ulike's Air 3 September 29, 2023
Ulike's 10th Anniversary Collaboration with PCOS Community NEW YORK, Sept. 29, 2023 /PRNewswire-PRWeb/ -- Marking its 10th anniversary, Ulike, a well-established name in at-home hair removal technology, is proud to strengthen its collaboration with the Polycystic Ovary Syndrome (PCOS)...
Northeast Delta HSA to host mental health art exhibition in Lincoln Parish, Ruston Artisans September 29, 2023
MONROE, LA - Northeast Delta Human Services Authority (NEDHSA) opens its Mental Health Art Exhibition at the Ruston Artisans Gallery beginning October 1, 2023, and will host an opening reception on Thursday, October 19 at 5 p.m. at 203 W. Alabama Avenue, Ruston, La. This exhibition is...
Global Call to Action on Sleep Health Published in The Lancet Public Health September 29, 2023
A global call to action was published in The Lancet Public Health on September 28 that urges decisionmakers to recognize sleep health as a foundation of human health. Decades of research across disciplines make this fact abundantly clear. Now is the time to begin leveraging sleep health...

Sonia Portillo

Study Reveals Higher Risks of HPV-Related Cancers in HIV-Infected Hispanic Adults

Executives from American Express and J.P. Morgan Join St. Baldrick’s Foundation...

Phase Ib/II Data of Durvalumab Plus Danvatirsen Shows Promise in Head...

Nivolumab + Low-dose Ipilimumab may be First Line Treatment in Some...

Novartis Plans to Acquire Endocyte to Expand Expertise in Radiopharmaceuticals

Dana-Farber to Investigate New Therapy for Brain Cancer

Study of AXL Inhibitor DS-1205 in EGFR-Mutated Metastatic Non-Small Cell Lung...

Novel Statistical Method Estimates Time to Metastasis of Breast Cancer

NanoValent Receives NIH SBIR Funding for Antibody-conjugated Nanoparticle Technology

Study Confirms CT Screening for Nodule Volume Management Reduces Lung Cancer...

LATEST NEWS

October Breast Cancer Awareness Month: Emphasizing Equity in Access to Early Detection

Breaking Barriers to Access: Empowering Vulnerable Populations with Cell and Gene Therapy

Understanding the True Impact of Microbiota on Cancer Development and Treatment

Language Barriers and the Impact on Cancer Care

Long-term Outcomes of Radiation Techniques for the Treatment of Locally Advanced NSCLC

October Breast Cancer Awareness Month: Emphasizing Equity in Access to Early Detection

Breaking Barriers to Access: Empowering Vulnerable Populations with Cell and Gene Therapy

Understanding the True Impact of Microbiota on Cancer Development and Treatment

Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics

How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?

Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’...